ADMINISTRATIVE CORE ABSTRACT The UAB Comprehensive Cancer Center's (UAB CCC) Senior Leadership and Administrative Unit work collaboratively under the leadership of the Director to develop, initiate, and implement the Center's strategic initiatives focused on achieving the Center's research mission. The CCC Administrative Unit serves as the central coordinating hub of the Center's activities with the primary goal of meeting the needs of Center members within the strategic framework developed by the Center's leadership. The Administrative Unit serves the CCC and its members through: 1) acquiring, maintaining and reporting data for informed strategic planning and decision support; 2) coordination and implementation of programmatic initiatives; 3) oversight and management of Center assets and resources including financial, space and facility; 4) facilitating faculty recruitment, 5) administering pilot grant and research development program; 6) representing the Center' interests with institutional administrative entities; 7) internal and external communications; and 9) grants management. The CCC Senior Leadership supports the mission of the Center through strategic planning and evaluation, oversight of CCC research activities, integration of the CCC's research themes across programmatic areas, and establishing collaborative relationships within the CCC, UAB and HudsonAlpha as well as with external institutions. Specifically, the CCC Senior Leaders provide oversight and guidance to the research programs, shared facilities, membership, strategic themes, resource management, and undergraduate, graduate and post-graduate cancer research training programs. The CCC Senior Leadership is comprised of eight eminent oncology scientists supported by the CCSG: Director ? Edward E. Partridge, MD Deputy Director ? Ravi Bhatia, MD, PhD HudsonAlpha President and CEO- Richard Myers, PhD Associate Director for Basic Research ? Etty (Tika) Benveniste, PhD Associate Director for Translational Research ? Mary-Ann Bjornsti, PhD Associate Director for Clinical Research ? Harry Erba, MD, PhD Associate Director for Prevention and Control ? Wendy Demark-Wahnefried, PhD Associate Director for Drug Discovery and Development ? Richard Whitley, MD Associate Director for Administration ? Michael J. Bertram, PhD, MBA

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA013148-44
Application #
9075049
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2016-04-06
Budget End
2017-03-31
Support Year
44
Fiscal Year
2016
Total Cost
Indirect Cost
Name
University of Alabama Birmingham
Department
Type
DUNS #
063690705
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Van Arsdale, Anne R; Arend, Rebecca C; Cossio, Maria J et al. (2018) Insulin-like growth factor 2: a poor prognostic biomarker linked to racial disparity in women with uterine carcinosarcoma. Cancer Med 7:616-625
Kim, Harrison (2018) Modification of population based arterial input function to incorporate individual variation. Magn Reson Imaging 45:66-71
Leath 3rd, Charles A; Monk, Bradley J (2018) Twenty-first century cervical cancer management: A historical perspective of the gynecologic oncology group/NRG oncology over the past twenty years. Gynecol Oncol 150:391-397
Park, Misun; Yoon, Young Sup (2018) Cardiac Regeneration with Human Pluripotent Stem Cell-Derived Cardiomyocytes. Korean Circ J 48:974-988
Toboni, Michael D; Smith, Haller J; Bae, Sejong et al. (2018) Predictors of Unplanned Reoperation for Ovarian Cancer Patients From the National Surgical Quality Improvement Program Database. Int J Gynecol Cancer 28:1427-1431
Dionne-Odom, J Nicholas; Applebaum, Allison J; Ornstein, Katherine A et al. (2018) Participation and interest in support services among family caregivers of older adults with cancer. Psychooncology 27:969-976
Demark-Wahnefried, Wendy; Schmitz, Kathryn H; Alfano, Catherine M et al. (2018) Weight management and physical activity throughout the cancer care continuum. CA Cancer J Clin 68:64-89
Bandari, Shyam K; Purushothaman, Anurag; Ramani, Vishnu C et al. (2018) Chemotherapy induces secretion of exosomes loaded with heparanase that degrades extracellular matrix and impacts tumor and host cell behavior. Matrix Biol 65:104-118
Gowda, Pramod S; Wildman, Benjamin J; Trotter, Timothy N et al. (2018) Runx2 Suppression by miR-342 and miR-363 Inhibits Multiple Myeloma Progression. Mol Cancer Res 16:1138-1148
Dix, Daniel B; McDonald, Andrew M; Gordetsky, Jennifer B et al. (2018) How Would MRI-targeted Prostate Biopsy Alter Radiation Therapy Approaches in Treating Prostate Cancer? Urology 122:139-146

Showing the most recent 10 out of 747 publications